Viewing nowCombinationFosiglip M Tablet 10/100 Milligrams
Sitagliptin Hydrochloride Hydrate 113.4mg · Dapagliflozin citric acid 14.7mg
Tablet · Prescription medication · Combination
Mothers Pharmaceutical Co., Ltd.

MFDS item code 202200488 · Approved 2022.01.28 · Insurance code 622805060
Improvement of glycemic control in patients with type 2 diabetes mellitus
This medication is used in conjunction with dietary and exercise regimens to assist in the blood sugar control of patients with type 2 diabetes who are using sitagliptin and dapagliflozin together. It helps effectively manage blood sugar and supports diabetes treatment.
This medicine may be administered as 1 tablet once daily, with or without food, to patients receiving sitagliptin 100 mg and dapagliflozin 10 mg. The tablet should be swallowed whole. No dose adjustment is necessary if the estimated glomerular filtration rate (eGFR) is 45 mL/min/1.73m2 or higher. Do not administer this medicine if the estimated glomerular filtration rate (eGFR) is below 45 mL/min/1.73 m2. No dose adjustment is necessary for patients with mild or moderate hepatic impairment. Use of this medicine is not recommended in patients with severe hepatic impairment.
This medication contains sitagliptin and dapagliflozin and is used in the treatment of diabetes. Firstly, sitagliptin may cause serious allergic reactions in some patients, so if symptoms such as rash, difficulty breathing, or swelling of the face or neck occur within the first 3 months after administration, treatment should be stopped immediately and a physician should be consulted. Additionally, acute pancreatitis, which is a serious side effect involving inflammation of the pancreas, has been reported, so if symptoms such as abdominal pain or vomiting occur, immediately discontinue the medication and notify healthcare personnel. Dapagliflozin should be used with caution in patients with impaired kidney function or reduced fluid volume. This medication may cause dehydration or hypotension due to its action of expelling glucose through urine, so elderly patients or those taking diuretics should regularly monitor blood pressure and kidney function. Furthermore, although rare, genital infections or urinary tract infections may occur, so immediate treatment should be sought if symptoms of infection appear. This medication should not be used in patients with type 1 diabetes, diabetic ketoacidosis, or in patients with lactose intolerance; it is also advisable not to use it in patients undergoing dialysis. Pregnant or breastfeeding women are advised not to use this medication, and if pregnancy is confirmed, treatment should be stopped immediately. During treatment with this medication, symptoms of hypoglycemia may occur, so when used with other hypoglycemic agents such as insulin or sulfonylureas, dosage adjustment may be necessary to reduce the risk of hypoglycemia. In cases of overdose, since there is no specific antidote, appropriate treatment should be administered according to symptoms, and blood dialysis may be considered if necessary. Finally, this medication has not been established for safety and efficacy in children under 18 years of age, so it should not be used in this population. In elderly patients, it is important to periodically evaluate kidney function when administering this medication. Patients taking this medication should be aware of the potential risk of hypoglycemia when driving or operating machinery and exercise caution.
Not everyone experiences these, and they can vary from person to person.
This medication should be stored in a tightly closed container to prevent exposure to air or moisture. It is best to store it at room temperature between 1 degree and 30 degrees Celsius.
Yellow oblong film-coated tablet
28 tablets/box [(7 tablets/PTP x 4)], 30 tablets/box [(10 tablets/PTP x 3)]
Even with the same ingredient, strength, dosage form and how it is taken can differ.
Viewing nowCombinationSitagliptin Hydrochloride Hydrate 113.4mg · Dapagliflozin citric acid 14.7mg
Tablet · Prescription medication · Combination
Mothers Pharmaceutical Co., Ltd.
Sitagliptin Hydrochloride Hydrate 113.4mg · Dapagliflozin citric acid 14.7mg
Tablet · Prescription medication · Combination
Daewon Pharmaceutical Co., Ltd.
Sitagliptin Hydrochloride Hydrate 113.4mg · Dapagliflozin citric acid 14.7mg
Tablet · Prescription medication · Combination
Genewon Science Co., Ltd.
CombinationSitagliptin Hydrochloride Hydrate 113.4mg · Dapagliflozin citric acid 14.7mg
Tablet · Prescription medication · Combination
Ilsung IS Co., Ltd.
CombinationSitagliptin Hydrochloride Hydrate 113.4mg · Dapagliflozin citric acid 14.7mg
Tablet · Prescription medication · Combination
Daewoong Bio Co., Ltd.
CombinationSitagliptin Hydrochloride Hydrate 113.4mg · Dapagliflozin citric acid 14.7mg
Tablet · Prescription medication · Combination
Withus Pharmaceutical Co., Ltd.
Sitagliptin Hydrochloride Hydrate 113.4mg · Dapagliflozin citric acid 14.7mg
Tablet · Prescription medication · Combination
Hanlim Pharmaceutical Co., Ltd.
CombinationSitagliptin Hydrochloride Hydrate 113.4mg · Dapagliflozin citric acid 14.7mg
Tablet · Prescription medication · Combination
Chodang Pharmaceutical Co., Ltd.
Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.
No questions yet.
For anything that needs medical judgment, consult a doctor or pharmacist.
This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.